US Patent

US9266861 — Method of synthesizing thyroid hormone analogs and polymorphs thereof

Composition of Matter · Assigned to Hoffmann La Roche Inc · Expires 2033-09-17 · 7y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects methods for synthesizing pyridazinone compounds, including thyroid hormone analogs and their prodrugs, and their morphic forms.

USPTO Abstract

The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.

Drugs covered by this patent

Patent Metadata

Patent number
US9266861
Jurisdiction
US
Classification
Composition of Matter
Expires
2033-09-17
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Hoffmann La Roche Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.